| Ticker Details |
CareDx, Inc.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
|
| IPO Date: |
July 17, 2014 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$2.51B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 3.34%
|
| Avg Daily Range (30 D): |
$1.47 | 3.84%
|
| Avg Daily Range (90 D): |
$0.95 | 3.32%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.99M |
| Avg Daily Volume (90 D): |
.76M |
| Trade Size |
| Avg Trade Size (Sh.): |
75 |
| Avg Trade Size (Sh.) (30 D): |
59 |
| Avg Trade Size (Sh.) (90 D): |
56 |
| Institutional Trades |
| Total Institutional Trades: |
3,655 |
| Avg Institutional Trade: |
$2.38M |
| Avg Institutional Trade (30 D): |
$3.59M |
| Avg Institutional Trade (90 D): |
$3.33M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.9M |
| Avg Closing Trade (30 D): |
$6.45M |
| Avg Closing Trade (90 D): |
$4.69M |
| Avg Closing Volume: |
119.57K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$2.16
|
$2.15
|
$.05
|
|
Diluted EPS
|
$2.08
|
$2.07
|
$.05
|
|
Revenue
|
$458.09M
|
$131.95M
|
$117.7M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$111.01M
|
$110.64M
|
$2.81M
|
|
Operating Income / Loss
|
$108.14M
|
$113.22M
|
$1.2M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$305.39M
|
$295.69M
|
$12.48M
|
|
PE Ratio
|
|
|
|
|
|
|
